Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Ischemic Heart Disease

  Free Subscription


Articles published in Circ J

Retrieve available abstracts of 144 articles:
HTML format



Single Articles


    April 2021
  1. BANDO YK
    Cancer and Coronary Heart Disease- To Bleed or Not to Bleed, That Is the Question.
    Circ J. 2021 Apr 8. doi: 10.1253/circj.CJ-21-0174.
    PubMed    


  2. ARAI R, Murata N, Yamada A, Monden M, et al
    Pitfall of Isolated Right Ventricular Infarction Caused by Non-Dominant Right Coronary Artery.
    Circ J. 2021 Apr 7. doi: 10.1253/circj.CJ-21-0108.
    PubMed    


    March 2021
  3. WATANABE M, Horie H, Kurata Y, Inoue Y, et al
    Esm1 and Stc1 as Angiogenic Factors Responsible for Protective Actions of Adipose-Derived Stem Cell Sheets on Chronic Heart Failure After Rat Myocardial Infarction.
    Circ J. 2021 Mar 12. doi: 10.1253/circj.CJ-20-0877.
    PubMed     Abstract available


  4. MATOBA T, Sakamoto K, Nakai M, Ichimura K, et al
    Institutional Characteristics and Prognosis of Acute Myocardial Infarction With Cardiogenic Shock in Japan- Analysis From the JROAD/JROAD-DPC Database.
    Circ J. 2021 Mar 4. doi: 10.1253/circj.CJ-20-0655.
    PubMed     Abstract available


  5. GOTO S, Ichihara G, Katsumata Y, Ko S, et al
    Time-Series Transcriptome Analysis Reveals the miR-27a-5p-Ppm1l Axis as a New Pathway Regulating Macrophage Alternative Polarization After Myocardial Infarction.
    Circ J. 2021 Mar 3. doi: 10.1253/circj.CJ-20-0783.
    PubMed     Abstract available


  6. PELLEGRINI D, Fiocca L, Pescetelli I, Canova P, et al
    Effect of Respiratory Impairment on the Outcomes of Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction and Coronavirus Disease-2019 (COVID-19).
    Circ J. 2021 Mar 2. doi: 10.1253/circj.CJ-20-1166.
    PubMed     Abstract available


    February 2021
  7. YAMAMOTO H, Takaya T, Nagai S, Takahashi Y, et al
    Coronary Computed Tomography Angiography-Guided Fibrinolytic Therapy for Extensive Thrombus in Reperfused ST-Elevation Myocardial Infarction.
    Circ J. 2021 Feb 11. doi: 10.1253/circj.CJ-20-1283.
    PubMed    


  8. UEDA Y, Tahara Y, Itoh T, Tsujita K, et al
    New Strategy to Prevent Acute Myocardial Infarction by Public Education- A Position Statement of the Committee on Public Education About Emergency Medical Care of the Japanese Circulation Society.
    Circ J. 2021 Feb 9. doi: 10.1253/circj.CJ-20-1308.
    PubMed     Abstract available


    January 2021
  9. WANG Y, Fang C, Zhang S, Li L, et al
    Predictors of Coronary Plaque Erosion in Current and Non-Current Smokers With ST-Segment Elevation Myocardial Infarction- An Optical Coherence Tomography Study.
    Circ J. 2021 Jan 28. doi: 10.1253/circj.CJ-20-0890.
    PubMed     Abstract available


  10. CHEW NW, Sia CH, Wee HL, Benedict LJ, et al
    Impact of the COVID-19 Pandemic on Door-to-Balloon Time for Primary Percutaneous Coronary Intervention- Results From the Singapore Western STEMI Network.
    Circ J. 2021;85:139-149.
    PubMed     Abstract available


  11. LIU R, Hu Y, Yang J, Wang Q, et al
    Effect of Baseline Thrombocytopenia on Long-Term Outcomes in Patients With Acute ST-Segment Elevated Myocardial Infarction- A Large Propensity Score-Matching Analysis From the China Acute Myocardial Infarction (CAMI) Registry.
    Circ J. 2021 Jan 14. doi: 10.1253/circj.CJ-20-0781.
    PubMed     Abstract available


  12. YEH YT, Hsu JC, Liao PC, Li AH, et al
    Modulators of Mortality Benefit From Peri-Angioplasty Adjunctive Tirofiban in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Circ J. 2021 Jan 14. doi: 10.1253/circj.CJ-20-0228.
    PubMed     Abstract available


  13. ISHIGUCHI H, Yasuda Y, Ishikura M, Yoshida M, et al
    Trends Over Time in the Incidences of ST-Segment Elevation Myocardial Infarction and Non-ST-Segment Elevation Myocardial Infarction During the Past Decade in a Rural Japanese High-Aged Population.
    Circ J. 2021 Jan 13. doi: 10.1253/circj.CJ-20-0955.
    PubMed     Abstract available


  14. KIM J, Song YB, Oh JH, Cho DK, et al
    Effects of Prolonged Dual Antiplatelet Therapy in ST-Segment Elevation vs. Non-ST-Segment Elevation Myocardial Infarction.
    Circ J. 2021 Jan 9. doi: 10.1253/circj.CJ-20-0704.
    PubMed     Abstract available


    November 2020
  15. ISHII H, Amano T, Yamaji K, Kohsaka S, et al
    Implementation of Percutaneous Coronary Intervention During the COVID-19 Pandemic in Japan- Nationwide Survey Report of the Japanese Association of Cardiovascular Intervention and Therapeutics for Cardiovascular Disease.
    Circ J. 2020;84:2185-2189.
    PubMed     Abstract available


  16. FUJII T, Ikari Y
    Predictive Ability of Academic Research Consortium for High Bleeding Risk Criteria in ST-Elevation Myocardial Infarction Patients Undergoing Primary Coronary Intervention.
    Circ J. 2020 Nov 11. doi: 10.1253/circj.CJ-20-0806.
    PubMed     Abstract available


    October 2020
  17. IWAHASHI N, Gohbara M, Kirigaya J, Abe T, et al
    Prognostic Significance of a Combination of QRS Score and E/e' Obtained 2 Weeks After the Onset of ST-Elevation Myocardial Infarction.
    Circ J. 2020 Oct 10. doi: 10.1253/circj.CJ-20-0486.
    PubMed     Abstract available


  18. ISHIDA M, Terashita D, Itoh T, Otake H, et al
    Vascular Response Occurring at 3 Months After Everolimus-Eluting Cobalt-Chromium Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction vs. Stable Coronary Artery Disease.
    Circ J. 2020 Oct 2. doi: 10.1253/circj.CJ-20-0264.
    PubMed     Abstract available


  19. NAKAMURA M, Kitazono T, Kozuma K, Sekine T, et al
    Prasugrel for Japanese Patients With Ischemic Heart Disease in Long-Term Clinical Practice (PRASFIT-Practice II)- Final 2-Year Follow-up Results of a Postmarketing Observational Study.
    Circ J. 2020 Oct 2. doi: 10.1253/circj.CJ-20-0253.
    PubMed     Abstract available


    September 2020
  20. NUMASAWA Y
    What Is the Most Preferable Treatment Strategy for Patients With Non-ST-Elevation Acute Coronary Syndrome With Multivessel Disease?- A Long-Term Perspective.
    Circ J. 2020;84:1686-1688.
    PubMed    


  21. FU R, Song C, Yang J, Gao C, et al
    A Practical Risk Score to Predict 24-Month Post-Discharge Mortality Risk in Patients With Non-ST-Segment Elevation Myocardial Infarction.
    Circ J. 2020 Sep 17. doi: 10.1253/circj.CJ-20-0509.
    PubMed     Abstract available


  22. ITO K, Kato K, Fukushima K, Tanaka H, et al
    Diagnosis of Spontaneous Reperfusion Case in Acute Myocardial Infarction by Fusion of Technetium-99 m Pyrophosphate/Thallium-201 Dual-Isotope Single Photon Emission CT Imaging and Contrast-Enhancement Coronary CT.
    Circ J. 2020 Sep 5. doi: 10.1253/circj.CJ-20-0360.
    PubMed    


    August 2020
  23. EREMIASOVA L, Hubacek JA, Danzig V, Adamkova V, et al
    Serum Bilirubin in the Czech Population- Relationship to the Risk of Myocardial Infarction in Males.
    Circ J. 2020 Aug 26. doi: 10.1253/circj.CJ-20-0192.
    PubMed     Abstract available


  24. CHEN PF, Yi JL, Pei JY, Tang L, et al
    Post-Procedural Anticoagulation After Primary Percutaneous Coronary Intervention for Anterior Acute Myocardial Infarction With Severe Left Ventricular Dysfunction.
    Circ J. 2020 Aug 26. doi: 10.1253/circj.CJ-19-1192.
    PubMed     Abstract available


  25. KOHSAKA S
    Identification of Patient-Related Factors in Stent Thrombosis.
    Circ J. 2020;84:1464-1466.
    PubMed    


  26. KANG J, Ahn H, Lee HS, Cho HJ, et al
    Still a Long Way to Go in Treating Cardiogenic Shock in Acute Myocardial Infarction.
    Circ J. 2020 Aug 8. doi: 10.1253/circj.CJ-20-0765.
    PubMed    


    July 2020
  27. ITO R, Yamashita J, Chikamori T, Kondo S, et al
    Clinical Differences of Recent Myocardial Infarction Compared With Acute Myocardial Infarction- Insights From the Tokyo CCU Network Multicenter Registry.
    Circ J. 2020 Jul 23. doi: 10.1253/circj.CJ-20-0333.
    PubMed     Abstract available


  28. LI T, Gu J, Yang O, Wang J, et al
    Bone Marrow Mesenchymal Stem Cell-Derived Exosomal miRNA-29c Decreases Cardiac Ischemia/Reperfusion Injury Through Inhibition of Excessive Autophagy via the PTEN/Akt/mTOR Signaling Pathway.
    Circ J. 2020;84:1304-1311.
    PubMed     Abstract available


  29. MIZUTANI Y, Ishikawa T, Watanabe S, Kobayashi S, et al
    Slowly Developed Coronary Artery Aneurysms in a Patient With Probable Kawasaki Disease.
    Circ J. 2020;84:1347.
    PubMed    


  30. CHOI KH, Yang JH, Hong D, Park TK, et al
    Optimal Timing of Venoarterial-Extracorporeal Membrane Oxygenation in Acute Myocardial Infarction Patients Suffering From Refractory Cardiogenic Shock.
    Circ J. 2020 Jul 17. doi: 10.1253/circj.CJ-20-0259.
    PubMed     Abstract available


    June 2020
  31. MAEDA T, Arima H
    Rural Health Disparities in Japan- Urgent Need for Big Data Utilization and Health Service Research.
    Circ J. 2020;84:1057-1058.
    PubMed    


  32. ONO K
    Prediction of Coronary Artery Disease by Measurement of Circulating MicroRNA-423-3p Levels.
    Circ J. 2020;84:1062-1063.
    PubMed    


  33. HOSHINO M, Yonetsu T, Sugiyama T, Kanaji Y, et al
    All Resting Physiological Indices May Not Be Equivalent- Comparison Between the Diastolic Pressure Ratio and Resting Full-Cycle Ratio.
    Circ J. 2020;84:1147-1154.
    PubMed     Abstract available


  34. YOSHIZAKI T, Kobayashi A, Nakamura T, Obata JE, et al
    Long-Term Follow-up of a Coronary Artery Aneurysm After Biodegradable-Polymer Sirolimus-Eluting Stent Implantation.
    Circ J. 2020;84:1196.
    PubMed    


  35. LIU Y, Jia SD, Yuan DS, Xu N, et al
    Apolipoprotein B/A-I Ratio Predicts Lesion Severity and Clinical Outcomes in Diabetic Patients With Acute Coronary Syndrome.
    Circ J. 2020;84:1132-1139.
    PubMed     Abstract available


  36. WANG X, Dong Y, Fang T, Wang X, et al
    Circulating MicroRNA-423-3p Improves the Prediction of Coronary Artery Disease in a General Population- Six-Year Follow-up Results From the China-Cardiovascular Disease Study.
    Circ J. 2020;84:1155-1162.
    PubMed     Abstract available


  37. NODA T, Nishigaki K, Minatoguchi S
    Safety and Efficacy of Human Muse Cell-Based Product for Acute Myocardial Infarction in a First-in-Human Trial.
    Circ J. 2020 Jun 11. doi: 10.1253/circj.CJ-20-0307.
    PubMed     Abstract available


    May 2020
  38. MATSUZAWA Y, Konishi M, Nakai M, Saigusa Y, et al
    In-Hospital Mortality in Acute Myocardial Infarction According to Population Density and Primary Angioplasty Procedures Volume.
    Circ J. 2020 May 27. doi: 10.1253/circj.CJ-19-0869.
    PubMed     Abstract available


  39. OHASHI K, Ouchi N, Murohara T
    Can Pharmacological Ischemic Preconditioning Affect Myocardial Ischemic Injury?
    Circ J. 2020;84:891-893.
    PubMed    


  40. KUROGI K, Ishii M, Sakamoto K, Komaki S, et al
    Optical Coherence Tomography-Guided Percutaneous Coronary Intervention With Low-Molecular-Weight Dextran- Effect on Renal Function.
    Circ J. 2020;84:917-925.
    PubMed     Abstract available


  41. WARISAWA T, Cook CM, Seligman H, Howard JP, et al
    Per-Vessel Level Analysis of Fractional Flow Reserve and Instantaneous Wave-Free Ratio Discordance- Insights From the AJIP Registry.
    Circ J. 2020;84:1034-1038.
    PubMed     Abstract available


  42. HANDA K, Yoshioka D, Toda K, Yokoyama JY, et al
    Surgical Results for Infective Endocarditis Complicated With Cardiogenic Shock.
    Circ J. 2020;84:926-934.
    PubMed     Abstract available


  43. UEMURA Y, Tanaka A, Takemoto K, Ishii H, et al
    Optical Coherence Tomography-Guided Stent Implantation for Woven Coronary Artery Anomaly.
    Circ J. 2020;84:1044.
    PubMed    


  44. DEGUCHI H, Ikeda M, Ide T, Tadokoro T, et al
    Roxadustat Markedly Reduces Myocardial Ischemia Reperfusion Injury in Mice.
    Circ J. 2020;84:1028-1033.
    PubMed     Abstract available


  45. BUCCHERI S
    Measuring Thrombogenicity in ST-Elevation Myocardial Infarction- Mechanistic Insights and Future Directions.
    Circ J. 2020 May 9. doi: 10.1253/circj.CJ-20-0256.
    PubMed    


  46. ARAI R, Yamada A, Mizobuchi S, Akutsu N, et al
    Clinical Implications of Cardiac Magnetic Resonance Imaging for Identifying Culprit Lesions in Patients With Suspected Multivessel Acute Myocardial Infarction.
    Circ J. 2020 May 9. doi: 10.1253/circj.CJ-20-0109.
    PubMed    


    April 2020
  47. LIU J, Wang S, Hou J, Cai H, et al
    Proteomics Profiling Reveals Insulin-Like Growth Factor 1, Collagen Type VI alpha-2 Chain, and Fermitin Family Homolog 3 as Potential Biomarkers of Plaque Erosion in ST-Segment Elevated Myocardial Infarction.
    Circ J. 2020 Apr 29. doi: 10.1253/circj.CJ-19-1206.
    PubMed     Abstract available


  48. ITO H, Wakatsuki T, Yamaguchi K, Fukuda D, et al
    Atherosclerotic Coronary Plaque Is Associated With Adventitial Vasa Vasorum and Local Inflammation in Adjacent Epicardial Adipose Tissue in Fresh Cadavers.
    Circ J. 2020;84:769-775.
    PubMed     Abstract available


  49. NAKAOKA H, Tsuda E, Morita Y, Kurosaki K, et al
    Cardiac Function by Magnetic Resonance Imaging in Coronary Artery Occlusions After Kawasaki Disease.
    Circ J. 2020;84:792-798.
    PubMed     Abstract available


  50. KOZUMA K, Tanabe K, Hamazaki Y, Okamura T, et al
    Long-Term Outcomes of Absorb Bioresorbable Vascular Scaffold vs. Everolimus-Eluting Metallic Stent- A Randomized Comparison Through 5 Years in Japan.
    Circ J. 2020;84:733-741.
    PubMed     Abstract available


  51. YAMAMOTO K, Natsuaki M, Morimoto T, Shiomi H, et al
    Transradial vs. Transfemoral Percutaneous Coronary Intervention in Patients With or Without High Bleeding Risk Criteria.
    Circ J. 2020;84:723-732.
    PubMed     Abstract available


  52. NAKAMURA M, Kimura K, Kimura T, Ishihara M, et al
    JCS 2020 Guideline Focused Update on Antithrombotic Therapy in Patients With Coronary Artery Disease.
    Circ J. 2020;84:831-865.
    PubMed    


  53. KHALIFA AKM, Kubo T, Ino Y, Terada K, et al
    Optical Coherence Tomography Comparison of Percutaneous Coronary Intervention Among Plaque Rupture, Erosion, and Calcified Nodule in Acute Myocardial Infarction.
    Circ J. 2020 Apr 18. doi: 10.1253/circj.CJ-20-0014.
    PubMed     Abstract available


    March 2020
  54. SATO N
    Clinical Significance of Heart Rate in Acute Cardiovascular Diseases- Simple But Meaningful.
    Circ J. 2020;84:542-543.
    PubMed    


  55. YUE Y, Huang S, Wang L, Wu Z, et al
    M2b Macrophages Regulate Cardiac Fibroblast Activation and Alleviate Cardiac Fibrosis After Reperfusion Injury.
    Circ J. 2020;84:626-635.
    PubMed     Abstract available


  56. WANG Y, Hao Y, Zhang H, Xu L, et al
    DNA Hypomethylation of miR-30a Mediated the Protection of Hypoxia Postconditioning Against Aged Cardiomyocytes Hypoxia/Reoxygenation Injury Through Inhibiting Autophagy.
    Circ J. 2020;84:616-625.
    PubMed     Abstract available


  57. NAKANO Y, Waseda K, Tajima A, Ando H, et al
    Effect of Deep Breathing in a Patient With Single Coronary Artery Compressed by Aorta and Pulmonary Artery- Intravascular Ultrasound and Fractional Flow Reserve Assessment.
    Circ J. 2020;84:677.
    PubMed    


  58. TANABE Y, Kido T, Kimura F, Kobayashi Y, et al
    Japanese Survey of Radiation Dose Associated With Coronary Computed Tomography Angiography- 2013 Data From a Multicenter Registry in Daily Practice.
    Circ J. 2020;84:601-608.
    PubMed     Abstract available


  59. MATSUMOTO S, Nakanishi R, Watanabe I, Aikawa H, et al
    Heart Rate After Resuscitation From Out-of-Hospital Cardiac Arrest due to Acute Coronary Syndrome Is an Independent Predictor of Clinical Outcome.
    Circ J. 2020;84:569-576.
    PubMed     Abstract available


  60. KIKUCHI S, Tsukahara K, Ichikawa S, Abe T, et al
    Platelet-Derived Thrombogenicity Measured by Total Thrombus-Formation Analysis System in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Circ J. 2020 Mar 19. doi: 10.1253/circj.CJ-19-1043.
    PubMed     Abstract available


    February 2020
  61. KANAZAWA H, Tsujita K
    Importance of Atrial Fibrillation in Heart Failure Patients With Preserved Ejection Fraction Without Coronary Artery Disease.
    Circ J. 2020;84:374-375.
    PubMed    


  62. NAGOSHI T
    Major Influence of Diabetes on Hospitalization for Heart Failure in Patients With Ischemic Heart Diseases.
    Circ J. 2020;84:382-383.
    PubMed    


  63. ORIGUCHI H, Itoh H, Momomura SI, Nohara R, et al
    Active Participation in Outpatient Cardiac Rehabilitation Is Associated With Better Prognosis After Coronary Artery Bypass Graft Surgery- J-REHAB CABG Study.
    Circ J. 2020;84:427-435.
    PubMed     Abstract available


  64. SUMINO Y, Sugiyama T, Hoshino M, Kanaji Y, et al
    Subclinical Calcified Nodules in Saphenous Vein Graft on High-Resolution Coronary Angioscopy.
    Circ J. 2020;84:532.
    PubMed    


  65. TEMMA T, Nagai T, Watanabe M, Kamada R, et al
    Differential Prognostic Impact of Atrial Fibrillation in Hospitalized Heart Failure Patients With Preserved Ejection Fraction According to Coronary Artery Disease Status- Report From the Japanese Nationwide Multicenter Registry.
    Circ J. 2020;84:397-403.
    PubMed     Abstract available


  66. MIZUNO Y, Harada E, Kugimiya F, Shono M, et al
    East Asians Variant Mitochondrial Aldehyde Dehydrogenase 2 Genotype Exacerbates Nitrate Tolerance in Patients With Coronary Spastic Angina.
    Circ J. 2020;84:479-486.
    PubMed     Abstract available


  67. TAKEJI Y, Shiomi H, Morimoto T, Furukawa Y, et al
    Diabetes Mellitus and Long-Term Risk for Heart Failure After Coronary Revascularization.
    Circ J. 2020;84:471-478.
    PubMed     Abstract available


  68. WANG C, Li P, Zhang F, Kong Q, et al
    Does Bilateral Internal Mammary Artery Grafting Better Suit Patients With Diabetes?- Two Different Ways to Explore Outcomes.
    Circ J. 2020;84:436-444.
    PubMed     Abstract available


  69. SATO T, Minami Y, Asakura K, Katamine M, et al
    Age- and Gender-Related Differences in Coronary Lesion Plaque Composition on Optical Coherence Tomography.
    Circ J. 2020;84:463-470.
    PubMed     Abstract available


    January 2020
  70. PENG L, Fu C, Liang Z, Zhang Q, et al
    Pulsed Electromagnetic Fields Increase Angiogenesis and Improve Cardiac Function After Myocardial Ischemia in Mice.
    Circ J. 2020;84:186-193.
    PubMed     Abstract available


  71. WATANABE Y, Sakakura K, Fujita H, Ohya M, et al
    Comparison of Clinical Characteristics of Stent Thrombosis Between the Right Coronary Artery and the Left Coronary Artery- A Subanalysis of the REAL-ST Registry.
    Circ J. 2020;84:169-177.
    PubMed     Abstract available


  72. TAN WCJ, Inoue K, AbdelWareth L, Giannitsis E, et al
    The Asia-Pacific Society of Cardiology (APSC) Expert Committee Consensus Recommendations for Assessment of Suspected Acute Coronary Syndrome Using High-Sensitivity Cardiac Troponin T in the Emergency Department.
    Circ J. 2020;84:136-143.
    PubMed     Abstract available


  73. JANG JY, Lee BK, Kim JS, Shin DH, et al
    Efficacy and Safety of Guideline-Recommended Risk Score-Directed Dual Antiplatelet Therapy After 2nd-Generation Drug-Eluting Stents.
    Circ J. 2020;84:161-168.
    PubMed     Abstract available


  74. ASAKURA K, Homma T, Akutsu N, Fukamachi D, et al
    Cardiac Rupture Due to Side Branch Occlusion After Stent Implantation- The Crime of Jailed Stent.
    Circ J. 2020;84:295.
    PubMed    


  75. YOSHIOKA N, Takagi K, Morishima I, Morita Y, et al
    CORRIGENDUM: Influence of Preadmission Frailty on Short- and Mid-Term Prognoses in Octogenarians With ST-Elevation Myocardial Infarction.
    Circ J. 2020;84:683.
    PubMed    


    November 2019
  76. YOSHIOKA N, Takagi K, Morishima I, Morita Y, et al
    Influence of Preadmission Frailty on Short- and Mid-Term Prognoses in Octogenarians With ST-Elevation Myocardial Infarction.
    Circ J. 2019 Nov 29. doi: 10.1253/circj.CJ-19-0467.
    PubMed     Abstract available


  77. NAKAMURA M, Kitazono T, Kozuma K, Sekine T, et al
    Prasugrel for Japanese Patients With Ischemic Heart Disease in Long-Term Clinical Practice (PRASFIT-Practice II)- 1-Year Follow-up Results of a Postmarketing Observational Study.
    Circ J. 2019 Nov 21. doi: 10.1253/circj.CJ-19-0645.
    PubMed     Abstract available


    September 2019
  78. ADACHI M, Watanabe M, Kurata Y, Inoue Y, et al
    beta-Adrenergic Blocker, Carvedilol, Abolishes Ameliorating Actions of Adipose-Derived Stem Cell Sheets on Cardiac Dysfunction and Remodeling After Myocardial Infarction.
    Circ J. 2019 Sep 13. doi: 10.1253/circj.CJ-19-0261.
    PubMed     Abstract available


    June 2019
  79. YASUDA S, Honda S, Takegami M, Nishihira K, et al
    Contemporary Antiplatelet Therapy and Clinical Outcomes of Japanese Patients With Acute Myocardial Infarction- Results From the Prospective Japan Acute Myocardial Infarction Registry (JAMIR).
    Circ J. 2019 Jun 14. doi: 10.1253/circj.CJ-19-0145.
    PubMed     Abstract available


  80. KODERA S, Morita H, Kiyosue A, Ando J, et al
    Cost-Effectiveness of Percutaneous Coronary Intervention Compared With Medical Therapy for Ischemic Heart Disease in Japan.
    Circ J. 2019 Jun 5. doi: 10.1253/circj.CJ-19-0148.
    PubMed     Abstract available


    May 2019
  81. ABE S, Nishino S, Sakuma M, Inoue T, et al
    Low Endothelial Sheer Stress- A Silent Killer.
    Circ J. 2019;83:1197-1199.
    PubMed    


  82. KONDO T, Nakano Y, Adachi S, Murohara T, et al
    Renin Activity as a Key Predictor of Major Adverse Cardiac Events.
    Circ J. 2019;83:1204-1205.
    PubMed    


    April 2019
  83. ELGENDY IY, Mahmoud AN, Elgendy AY, Mintz GS, et al
    Intravascular Ultrasound-Guidance Is Associated With Lower Cardiovascular Mortality and Myocardial Infarction for Drug-Eluting Stent Implantation- Insights From an Updated Meta-Analysis of Randomized Trials.
    Circ J. 2019 Apr 26. doi: 10.1253/circj.CJ-19-0209.
    PubMed     Abstract available


  84. YOSHIDA H
    Clinical Impact and Significance of Serum Lipoprotein (a) Levels on Cardiovascular Risk in Patients With Coronary Artery Disease.
    Circ J. 2019;83:967-968.
    PubMed    


  85. OHMURA H
    Triglycerides as Residual Risk for Atherosclerotic Cardiovascular Disease.
    Circ J. 2019;83:969-970.
    PubMed    


  86. UEMURA S, Okamoto H, Nakai M, Nishimura K, et al
    Primary Percutaneous Coronary Intervention in Elderly Patients With Acute Myocardial Infarction- An Analysis From a Japanese Nationwide Claim-Based Database.
    Circ J. 2019 Apr 24. doi: 10.1253/circj.CJ-19-0004.
    PubMed     Abstract available


  87. YAMAMOTO T, Yoshida N, Takayama M
    Temporal Trends in Acute Myocardial Infarction Incidence and Mortality Between 2006 and 2016 in Tokyo- Report From the Tokyo CCU Network.
    Circ J. 2019 Apr 20. doi: 10.1253/circj.CJ-19-0187.
    PubMed     Abstract available


  88. KAMON D, Okura H, Okamura A, Nakada Y, et al
    Plasma Renin Activity Is an Independent Prognosticator in Patients With Myocardial Infarction.
    Circ J. 2019 Apr 20. doi: 10.1253/circj.CJ-18-1195.
    PubMed     Abstract available


  89. BRYNIARSKI KL, Wang Z, Fracassi F, Sugiyama T, et al
    Three-Dimensional Fibrous Cap Structure of Coronary Lipid Plaque- ST-Elevation Myocardial Infarction vs. Stable Angina.
    Circ J. 2019 Apr 13. doi: 10.1253/circj.CJ-19-0007.
    PubMed     Abstract available


    March 2019
  90. OKUNO T, Aoki J, Tanabe K, Nakao K, et al
    Admission Heart Rate Is a Determinant of Effectiveness of Beta-Blockers in Acute Myocardial Infarction Patients.
    Circ J. 2019 Mar 30. doi: 10.1253/circj.CJ-18-0995.
    PubMed     Abstract available


  91. YAMAMOTO K, Sakakura K, Akashi N, Watanabe Y, et al
    Novel Acute Myocardial Infarction Risk Stratification (nARS) System Reduces the Length of Hospitalization for Acute Myocardial Infarction.
    Circ J. 2019 Mar 19. doi: 10.1253/circj.CJ-18-1221.
    PubMed     Abstract available


  92. TABATA H, Motoki H, Sakai T, Okada A, et al
    Epicardial Stone- Unfamiliar Calcified Mass at the Site of Left Ventricular Old Myocardial Infarction.
    Circ J. 2019 Mar 6. doi: 10.1253/circj.CJ-18-1102.
    PubMed    


  93. HAYASHI R, Iso H, Yamagishi K, Yatsuya H, et al
    Working Hours and Risk of Acute Myocardial Infarction and Stroke Among Middle-Aged Japanese Men- The Japan Public Health Center-Based Prospective Study Cohort II.
    Circ J. 2019 Mar 6. doi: 10.1253/circj.CJ-18-0842.
    PubMed     Abstract available


    February 2019
  94. HAN SH, Koh KK
    Importance of Risk Stratification After Myocardial Infarction and the Need for Its Clinical Application.
    Circ J. 2019 Feb 28. doi: 10.1253/circj.CJ-19-0112.
    PubMed    


  95. HATASA M, Tanaka T, Minatoguchi S, Yamada Y, et al
    Increased Plasma Adenosine Concentration in the Subacute Phase May Contribute to Attenuation of Left Ventricular Dilation in the Chronic Phase in Patients With Acute Myocardial Infarction.
    Circ J. 2019 Feb 26. doi: 10.1253/circj.CJ-18-1107.
    PubMed     Abstract available


  96. KANEKO H, Komuro I
    C-Reactive Protein and Chronic Inflammation- Is It a Novel Therapeutic Target for Subsequent Cancer Death in Patients With Coronary Artery Disease?
    Circ J. 2019;83:513-514.
    PubMed    


  97. HUANG D, Cheng YY, Wong YA, Yung SA, et al
    Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention of Recurrent Cardiovascular Events in a Real-World Cohort of Post-Acute Myocardial Infarction Patients.
    Circ J. 2019 Feb 22. doi: 10.1253/circj.CJ-18-0308.
    PubMed     Abstract available


    January 2019
  98. MATOBA T, Nakano Y, Tsutsui H
    Unexpected, But Reasonable Association Between Anderson-Fabry Disease and Coronary Vasospasm.
    Circ J. 2019;83:283-284.
    PubMed    


  99. AOKI T
    Beneficial Prognostic Effects of Statins in Heart Failure With Preserved Ejection Fraction (HFpEF) Patients- HFpEF as a Manifestation of Systemic Disease.
    Circ J. 2019;83:277-278.
    PubMed    


  100. NAKAMURA M, Kozuma K, Kitazono T, Iizuka T, et al
    Prasugrel for Japanese Patients With Ischemic Heart Disease in Long-Term Clinical Practice (PRASFIT-Practice II)- A 3-Month Interim Analysis of a Postmarketing Observational Study.
    Circ J. 2019 Jan 24. doi: 10.1253/circj.CJ-18-0956.
    PubMed     Abstract available


  101. OZASA N, Kimura T
    Oral beta-Blocker Therapy in Acute Myocardial Infarction.
    Circ J. 2019 Jan 12. doi: 10.1253/circj.CJ-18-1364.
    PubMed    


    December 2018
  102. TAKASE S
    Does the Cardiac Surgeon Accept Coronary Artery Bypass Grafting With Incomplete Revascularization for Patients With Low Ventricular Function and Complex Multivessel Coronary Disease?
    Circ J. 2018 Dec 8. doi: 10.1253/circj.CJ-18-1241.
    PubMed    


    November 2018
  103. HWANG D, Lee JM, Kim HK, Choi KH, et al
    Prognostic Impact of beta-Blocker Dose After Acute Myocardial Infarction.
    Circ J. 2018 Nov 22. doi: 10.1253/circj.CJ-18-0662.
    PubMed     Abstract available


  104. KOBAYASHI Y, Tanno K, Ueno A, Fukamizu S, et al
    In-Hospital Electrical Storm in Acute Myocardial Infarction- Clinical Background and Mechanism of the Electrical Instability.
    Circ J. 2018 Nov 15. doi: 10.1253/circj.CJ-18-0785.
    PubMed     Abstract available


    October 2018
  105. OKADA M, Kashiwase K, Hirata A, Nishio M, et al
    Evaluation of Need for Implantable Cardioverter-Defibrillator by Thallium-201 Scintigraphy Among Japanese Patients With Prior Myocardial Infarction.
    Circ J. 2018 Oct 31. doi: 10.1253/circj.CJ-17-1436.
    PubMed     Abstract available


    September 2018
  106. ZHU J, Gu H, Lv X, Yuan C, et al
    LINC-PINT Activates the Mitogen-Activated Protein Kinase Pathway to Promote Acute Myocardial Infarction by Regulating miR-208a-3p.
    Circ J. 2018 Sep 22. doi: 10.1253/circj.CJ-18-0396.
    PubMed     Abstract available


  107. KANAOKA K, Okayama S, Yoneyama K, Nakai M, et al
    Number of Board-Certified Cardiologists and Acute Myocardial Infarction-Related Mortality in Japan- JROAD and JROAD-DPC Registry Analysis.
    Circ J. 2018 Sep 12. doi: 10.1253/circj.CJ-18-0487.
    PubMed     Abstract available


    August 2018
  108. SUGIURA J, Watanabe M, Toyokawa N, Kamon D, et al
    Progression of a Calcified Nodule Causing Acute Myocardial Infarction in a Patient on Hemodialysis- Serial Optical Coherence Tomography.
    Circ J. 2018 Aug 24. doi: 10.1253/circj.CJ-18-0515.
    PubMed    


  109. CHA S, Park JJ, Kim S, Ahn HY, et al
    Need for Systematic Efforts to Modify Health-Related Behaviors After Acute Myocardial Infarction in Korea.
    Circ J. 2018 Aug 1. doi: 10.1253/circj.CJ-17-1405.
    PubMed     Abstract available


    July 2018
  110. SHIMODA M, Ando H, Naito K, Suzuki A, et al
    Early-Phase Vascular Healing of Bioabsorbable vs. Durable Polymer-Coated Everolimus-Eluting Stents in Patients With ST-Elevation Myocardial Infarction- 2-Week and 4-Month Analyses With Optical Coherence Tomography.
    Circ J. 2018 Jul 11. doi: 10.1253/circj.CJ-18-0230.
    PubMed     Abstract available


    June 2018
  111. FU R, Song C, Yang J, Wang Y, et al
    CAMI-NSTEMI Score- China Acute Myocardial Infarction Registry-Derived Novel Tool to Predict In-Hospital Death in Non-ST Segment Elevation Myocardial Infarction Patients.
    Circ J. 2018 Jun 8. doi: 10.1253/circj.CJ-17-1078.
    PubMed     Abstract available


    May 2018
  112. KAIKITA K, Yoshimura H, Ishii M, Kudoh T, et al
    Tailored Adjunctive Cilostazol Therapy Based on CYP2C19 Genotyping in Patients With Acute Myocardial Infarction- The CALDERA-GENE Study.
    Circ J. 2018 May 8. doi: 10.1253/circj.CJ-18-0197.
    PubMed     Abstract available


    April 2018
  113. CHIEN KL, Lin HJ, Su TC, Chen YY, et al
    Comparing the Consistency and Performance of Various Coronary Heart Disease Prediction Models for Primary Prevention Using a National Representative Cohort in Taiwan.
    Circ J. 2018 Apr 27. doi: 10.1253/circj.CJ-17-0910.
    PubMed     Abstract available


  114. KIM MC, Jeong MH, Sim DS, Hong YJ, et al
    Comparison of Clinical Outcomes Between Ticagrelor and Prasugrel in Patients With ST-Segment Elevation Myocardial Infarction- Results From the Korea Acute Myocardial Infarction Registry-National Institutes of Health.
    Circ J. 2018 Apr 12. doi: 10.1253/circj.CJ-18-0112.
    PubMed     Abstract available


  115. TANABE K
    Is There Any Impact of ST Re-elevation on Patients With Acute Myocardial Infarction Following Reperfusion Therapy?
    Circ J. 2018 Apr 5. doi: 10.1253/circj.CJ-18-0320.
    PubMed    


    March 2018
  116. MASUDA J, Kishi M, Kumagai N, Yamazaki T, et al
    Rural-Urban Disparity in Emergency Care for Acute Myocardial Infarction in Japan.
    Circ J. 2018 Mar 27. doi: 10.1253/circj.CJ-17-1275.
    PubMed     Abstract available


  117. GOTO M
    Exploring Deep Into the Coronary Microcirculation of Patients With Microvascular Angina.
    Circ J. 2018;82:951-953.
    PubMed    


  118. UETANI T, Amano T
    Current Status of Rotational Atherectomy in the Drug-Eluting Stent Era.
    Circ J. 2018;82:946-947.
    PubMed    


    February 2018
  119. HWANG D, Kim HK, Lee JM, Choi KH, et al
    Effects of Statin Intensity on Clinical Outcome in Acute Myocardial Infarction Patients.
    Circ J. 2018 Feb 28. doi: 10.1253/circj.CJ-17-1221.
    PubMed     Abstract available


  120. MINAMINO T, Higo S, Araki R, Hikoso S, et al
    Low-Dose Erythropoietin in Patients With ST-Segment Elevation Myocardial Infarction (EPO-AMI-II)- A Randomized Controlled Clinical Trial.
    Circ J. 2018 Feb 2. doi: 10.1253/circj.CJ-17-0889.
    PubMed     Abstract available


    January 2018
  121. SUZUYAMA H, Sakamoto T, Nakao K
    Impact of Stent Type on the Long-Term Prognosis of Patients With Vasospastic Angina- Can We Judge a Stent Just by Its Cover?
    Circ J. 2018;82:328-329.
    PubMed    


  122. JIA H, Kubo T, Akasaka T, Yu B, et al
    Optical Coherence Tomography Guidance in Management of Acute Coronary Syndrome Caused by Plaque Erosion.
    Circ J. 2018;82:302-308.
    PubMed     Abstract available


  123. NISHIDA K, Nakatsuma K, Shiomi H, Natsuaki M, et al
    Second-Generation vs. First-Generation Drug-Eluting Stents in Patients With Calcified Coronary Lesions- Pooled Analysis From the RESET and NEXT Trials.
    Circ J. 2018;82:376-387.
    PubMed     Abstract available


  124. OKAI I, Dohi T, Okazaki S, Jujo K, et al
    Clinical Characteristics and Long-Term Outcomes of Rotational Atherectomy- J2T Multicenter Registry.
    Circ J. 2018;82:369-375.
    PubMed     Abstract available


  125. TELLO-MONTOLIU A, Rivera J, Hernandez D, Silvente A, et al
    Temporal Changes in Platelet Response in Acute Coronary Syndrome Patients With Prasugrel and Clopidogrel After Stent Implantation.
    Circ J. 2018;82:353-360.
    PubMed     Abstract available


  126. KAWAGUCHI N, Okayama H, Kawamura G, Shigematsu T, et al
    Clinical Usefulness of Coronary Flow Reserve Ratio for the Detection of Significant Coronary Artery Disease on (13)N-Ammonia Positron Emission Tomography.
    Circ J. 2018;82:486-493.
    PubMed     Abstract available


  127. SATO F, Maeda N, Yamada T, Namazui H, et al
    Association of Epicardial, Visceral, and Subcutaneous Fat With Cardiometabolic Diseases.
    Circ J. 2018;82:502-508.
    PubMed     Abstract available


  128. MIYOSHI T, Kohno K, Asonuma H, Sakuragi S, et al
    Effect of Intensive and Standard Pitavastatin Treatment With or Without Eicosapentaenoic Acid on Progression of Coronary Artery Calcification Over 12 Months- Prospective Multicenter Study.
    Circ J. 2018;82:532-540.
    PubMed     Abstract available


  129. ASANO T, Suwannasom P, Katagiri Y, Miyazaki Y, et al
    First-in-Man Trial of SiO2 Inert-Coated Bare Metal Stent System in Native Coronary Stenosis- The AXETIS FIM Trial.
    Circ J. 2018;82:477-485.
    PubMed     Abstract available


  130. HATA R, Oka N, Kubo S, Kuwayama A, et al
    Impact of Stent Type and Presence of Vasospastic Angina on Long-Term Prognosis.
    Circ J. 2018;82:469-476.
    PubMed     Abstract available


  131. EMORI H, Kubo T, Kameyama T, Ino Y, et al
    Diagnostic Accuracy of Quantitative Flow Ratio for Assessing Myocardial Ischemia in Prior Myocardial Infarction.
    Circ J. 2018 Jan 16. doi: 10.1253/circj.CJ-17-0949.
    PubMed     Abstract available


  132. MCCARTHY CP, Januzzi JL Jr, Gaggin HK
    Type 2 Myocardial Infarction- An Evolving Entity.
    Circ J. 2018 Jan 13. doi: 10.1253/circj.CJ-17-1399.
    PubMed     Abstract available


    December 2017
  133. LIU R, Zheng W, Zhao G, Wang X, et al
    Predictive Validity of CRUSADE, ACTION and ACUITY-HORIZONS Bleeding Risk Scores in Chinese Patients With ST-Segment Elevation Myocardial Infarction.
    Circ J. 2017 Dec 12. doi: 10.1253/circj.CJ-17-0760.
    PubMed     Abstract available


    November 2017
  134. TAKAHASHI H, Ozeki M, Fujisaka T, Morita H, et al
    Changes in Serum Fibroblast Growth Factor 23 in Patients With Acute Myocardial Infarction.
    Circ J. 2017 Nov 18. doi: 10.1253/circj.CJ-17-0826.
    PubMed     Abstract available


  135. TSUBURAYA R
    Mitochondrial Dysfunction and Left Ventricular Structural Remodeling After Acute Myocardial Infarction- Usefulness of Leukocyte Mitochondrial Copy Number.
    Circ J. 2017 Nov 3. doi: 10.1253/circj.CJ-17-1146.
    PubMed    


    October 2017
  136. LEE CH, Cheng CL, Kao Yang YH, Chao TH, et al
    Cardiovascular and Bleeding Risks in Acute Myocardial Infarction Newly Treated With Ticagrelor vs. Clopidogrel in Taiwan.
    Circ J. 2017 Oct 27. doi: 10.1253/circj.CJ-17-0632.
    PubMed     Abstract available


    September 2017
  137. CUENIN L, Lamoureux S, Schaaf M, Bochaton T, et al
    Incidence and Significance of Spontaneous ST Segment Re-elevation After Reperfused Anterior Acute Myocardial Infarction- Relationship With Infarct Size, Adverse Remodeling, and Events at 1 Year.
    Circ J. 2017 Sep 23. doi: 10.1253/circj.CJ-17-0671.
    PubMed     Abstract available


  138. TANAKA T, Nishigaki K, Minatoguchi S, Nawa T, et al
    Mobilized Muse Cells After Acute Myocardial Infarction Predict Cardiac Function and Remodeling in the Chronic Phase.
    Circ J. 2017 Sep 20. doi: 10.1253/circj.CJ-17-0552.
    PubMed     Abstract available


    August 2017
  139. MATSUO H, Honye J
    Fractional Flow Reserve in Japanese Routine Clinical Practice.
    Circ J. 2017;81:1270-1271.
    PubMed    


    May 2017
  140. LEI Y, Hu L, Yang G, Piao L, et al
    Dipeptidyl Peptidase-IV Inhibition for the Treatment of Cardiovascular Disease- Recent Insights Focusing on Angiogenesis and Neovascularization.
    Circ J. 2017;81:770-776.
    PubMed     Abstract available


  141. OZAKI Y, Imanishi T, Hosokawa S, Nishiguchi T, et al
    Association of Toll-Like Receptor 4 on Human Monocyte Subsets and Vulnerability Characteristics of Coronary Plaque as Assessed by 64-Slice Multidetector Computed Tomography.
    Circ J. 2017;81:837-845.
    PubMed     Abstract available


  142. SUEDA S, Kohno H
    Differential Incidence and Morphology of Spasm According to Coronary Arterial Location by Intracoronary Ergonovine Spasm Provocation Testing.
    Circ J. 2017;81:831-836.
    PubMed     Abstract available


  143. KIM TK, Hong DM, Choi YH, Koo CH, et al
    Preoperative Serum Alkaline Phosphatase and Clinical Outcome of Off-Pump Coronary Artery Bypass Surgery.
    Circ J. 2017;81:799-805.
    PubMed     Abstract available


  144. IKEMURA N, Sawano M, Shiraishi Y, Ueda I, et al
    Barriers Associated With Door-to-Balloon Delay in Contemporary Japanese Practice.
    Circ J. 2017;81:815-822.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: